Nonstatin Cholesterol Medications - NEXLIZET® NEXLETOL® NEXLIZET and NEXLETOL are the only oral nonstatins FDA approved to lower bad cholesterol and reduce the risk* of the first or next serious heart event † in patients with statin intolerance *Bempedoic acid † Serious heart event=cardiovascular death, heart attack, stroke, heart stent or bypass surgery
Nexlizet: Uses, Dosage, Side Effects, Warnings - Drugs. com Nexlizet has a dual mechanism of action The bempedoic acid component lowers LDL-C blood levels by blocking an enzyme involved in the production of cholesterol by the liver This helps restore blood flow in adults with or at high risk of cardiovascular disease (CVD) who cannot take statins
Nexlizet (bempedoic acid ezetimibe) - Uses, Side . . . - WebMD Nexlizet reduces cholesterol by decreasing the amount made by your liver and increasing the breakdown of bad cholesterol It also inhibits the absorption of cholesterol in the intestines
NEXLIZET® NEXLETOL® HCP Information - Official Site Indication NEXLIZET and NEXLETOL are indicated: bempedoic acid, a component of NEXLIZET and NEXLETOL, is indicated to reduce the risk of major adverse cardiovascular events (cardiovascular death, myocardial infarction, stroke, or coronary revascularization) in adults at increased risk for these events who are unable to take recommended statin therapy (including those not taking a statin) as
Nexlizet: Uses, Side Effects, Dosage More - GoodRx Nexlizet is a brand-name combination medication that treats adults with high cholesterol, including those with a genetic condition called familial hypercholesterolemia For adults at risk for heart disease who aren't taking statins, Nexlizet can help lower the risk of heart attack and the need for a procedure to open blocked arteries to help blood flow to the heart (e g , stent placement
PATIENT INFORMATION NEXLIZET (NEX-lee-zet) (bempedoic acid . . . Bempedoic acid, a component of NEXLIZET, is used: to lower the risk of major adverse cardiovascular (CV) events, such as death from cardiovascular disease, heart attack, stroke, or heart procedures like stent placement or bypass surgery in adults at increased risk for these events who are unable to take recommended statin treatment (a cholesterol-lowering medicine), or are not taking a statin
label - accessdata. fda. gov INDICATIONS AND USAGE NEXLIZET, a combination of bempedoic acid and ezetimibe, is indicated: • As an adjunct to diet, alone or in combination with other low-density lipoprotein cholesterol (LDL-C) lowering therapies, to reduce LDL-C in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH)
Nexlizet (Bempedoic acid and Ezetimibe) for Heart Disease Overview Nexlizet is a prescription drug approved by the U S Food and Drug Administration (FDA) to treat adults with heterozygous familial hypercholesterolemia or established atherosclerotic cardiovascular disease who require additional lowering of low-density lipoprotein cholesterol (LDL-C)
Nexlizet: Side Effects, Cost, Uses, Dosage, and More - Healthline Nexlizet (bempedoic acid ezetimibe) is a prescription tablet used to help lower cholesterol and reduce the risk of heart attack as well as heart surgery Nexlizet is prescribed for certain adults